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Received 7 August 2008; received in revised form 7 August 2009; accepted 8 August 2009Abstract Embryonic stem cells (ESCs) are a renewable cell source of tissue for regenerative therapies. The addition of bone
morphogenetic protein 4 (BMP4) to serum-free ESC cultures can induce primitive streak-like mesodermal cells. In differentiated
mouse ESCs, platelet-derived growth factor receptor-α (PDGFR-α) and E-cadherin (ECD) are useful markers to distinguish
between paraxial mesodermal progenitor cells and undifferentiated and endodermal cells, respectively. Here, we demonstrate
methods for BMP4-mediated induction of paraxial mesodermal progenitors using PDGFR-α and ECD as markers for purification
and characterization. Serum-free monolayers of ESCs cultured with BMP4 could efficiently promote paraxial mesodermal
differentiation akin to embryonic mesodermal development. BMP4 treatment alone induced paraxial mesodermal progenitors
that could differentiate into osteochondrogenic cells in vitro and in vivo. Furthermore, early removal of BMP4 followed by
lithium chloride (LiCl) promoted the differentiation to myogenic progenitor cells. These myogenic progenitors were able to
differentiate further in vitro into mature skeletal muscle cells. Thus, we successfully induced the efficient bidirectional
differentiation of mouse ESCs toward osteochondrogenic and myogenic cell types using chemically defined conditions.
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Embryonic stem cells (ESCs), with their abundant potential
of self-renewal and differentiation into all cell lineages,
have been investigated both as an experimental tool for
developmental biology and as a new source of cell-based
therapy. Differentiation of ESCs under chemically defined
conditions (i.e., by adding or removing specific factors)
enables analysis of the molecular processes of early
developmental events (Nishikawa et al., 2007) and is
desirable for clinical applications because it eliminates the
risk of viral or prion infection from biomaterials.
Specification of the mesoderm is established following
gastrulation by a process initiated in the posterior region of
the embryo resulting in the formation of the primitive streak.
The primitive streak contains mesodermal cells that migrate
laterally and diverge into three mesodermal lineages which
are defined by their distances from the axis: paraxial,
intermediate, and lateral. At approximately 6.5 days of
mouse development, a gradient of bone morphogenetic
protein (BMP) signaling is established along the proximal-
distal axis of the embryo with restricted BMP4 expression in
the proximal region and BMP antagonist expression in the
distal region (McMahon et al., 1998); (Bachiller et al., 2000).
Targeted disruption of BMP4 revealed that BMP4 plays a
critical role in primitive streak formation (Winnier et al.,
1995). The administration of recombinant BMP4 to mouse
ESC culture induces expression of primitive streak and
primitive streak-derived mesoderm-specific genes such as
the T-box transcriptional factor Brachyury (T), Mixl1, Tbx6,
and VEGFR2 (Johansson and Wiles, 1995; Ng et al., 2005; Era
et al., 2008), and inhibits neuronal development (Kawasaki
et al., 2000). Many lateral mesodermal derivatives have been
induced by BMP4 stimulation including hematopoietic cells
(Pick et al., 2007), endothelial cells (Park et al., 2004),
cardiomyocytes (Honda et al., 2006), and intermediate
mesodermal derivatives such as renal progenitors (Bruce et
al., 2007). However, differentiation of paraxial mesodermal
derivatives from ESCs in serum-free culture has remained
elusive.
Previously, we demonstrated that platelet-derived
growth factor receptor-α (PDGFR-α) expression was a marker
for the paraxial mesodermal progenitors in differentiated
mouse ESCs (Sakurai et al., 2006). The expression of PDGFR-α
is found in paraxial mesoderm, somites, neural tube, and
spinal chord during mouse embryogenesis (Kataoka et al.,
1997; Schatteman et al., 1992). In vitro fate analyses of ESC-
derived PDGFR-α+ cells demonstrated their potential to
differentiate into osteocytes, chondrocytes, and skeletal
muscle cells, which are derivatives of somites (Sakurai et al.,
2006; Nakayama et al., 2003). We have also demonstrated
that PDGFR-α+ cells can be subdivided into PDGFR-α+/
VEGFR2+ and PDGFR-α+/VEGFR2- cells (Sakurai et al.,
2006). The PDGFR-α+/VEGFR2- cells mainly consist of
paraxial mesodermal progenitors, while the PDGFR-α+/
VEGFR2+ cells have the bipotential to differentiate into
both paraxial and lateral mesodermal progenitors. However,
in paraxial mesoderm induction, the PDGFR-α+/VEGFR2+
cells can differentiate into paraxial mesodermal derivatives,
as well as PDGFR-α+/VEGFR2- cells. Indeed, in the previous
study, we demonstrated that PDGFR-α+ cells could differen-
tiate into muscle satellite cells but not into vascularendothelial cells in intramuscular transplantation (Sakurai
et al., 2008). Therefore, we handled the PDGFR-α+/VEGFR-2-
and the PDGFR-α+/VEGFR-2+ population as a single popula-
tion of paraxial mesodermal progenitors. However, the
percentage of PDGFR-α+ cells in conventional serum-con-
taining differentiation media is limited to no more than 40%
of the differentiated cells (Sakurai et al., 2006).
Here, we report the development of serum-free culture
systems supplemented with BMP4 or LiCl to efficiently
differentiate osteochondrogenic and myogenic paraxial
mesodermal progenitors. Our system was established with-
out the use of gene manipulation to isolate/enrich the
paraxial mesodermal progenitors. Instead we used the
paraxial mesodermal marker PDGFR-α and the undifferenti-
ated cell marker E-cadherin (ECD) for sorting and charac-
terizing cell subpopulations. Our findings should facilitate
the generation of bone, cartilage, and skeletal muscle from
human pluripotent stem cells for future clinical applications.
Results
Paraxial mesodermal differentiation of ESCs in
BMP4-supplemented serum-free culture
BMP4 promoted the expression of PDGFR-α in a dose-
dependent manner during in vitro ESC differentiation
(Fig. 1a). When ESCs were differentiated without BMP4 for
6 days, only 3% of the cells expressed PDGFR-α. Inclusion of
low doses of BMP4 (0.1 or 0.3 ng/ml) had little impact on
differentiation. However, moderate doses of BMP4 (1 to
10 ng/ml) induced up to half of the cells to express PDGFR-α
(Fig. 1a). We used BMP4 for differentiation to mesoderm at
1 ng/ml in the following studies. Cell density inversely
affected the expression of the PDGFR-α, with greater
frequency of expression of PDGFR-α occurring below 2×105
cells per 10-cm dish (Fig. 1b). However, the extent of ESC
proliferation over a 6-day period was the greatest when
starting at 2×105 cells per 10-cm dish, increasing about 15-
fold during differentiation (Fig. 1c). Total PDGFR-α+ cell
number was also the highest at the starting cell density of
2×105 per 10-cm dish, increasing about 5-fold to input cell
number (Fig. 1c). In the higher starting cell density, viable
harvested cell number was reduced, indicating that the
proliferation of ESCs was inhibited in the higher cell density
(Fig. 1c).
Based on these results, we plated the ESCs at a density of
2×105 cells per 10-cm dish in the following studies. PDGFR-α+
cells emerged after 4 days of differentiation reaching a peak
on Day 5, with almost half of the cells becoming PDGFR-α+
(Fig. 1d, upper row). The morphology of the cell aggregates
changed from ESC-like round colonies to cobblestone
monolayers (Fig. 1d, lower row). Total PDGFR-α+ cell number
was increasing in a time-dependent manner for 7 days of
differentiation and we obtained about 11-fold increase of
PDGFR-α+ cells over the number of input ESCs (Fig. 1e).
Serum-free culture was superior to serum-containing culture
on the production of PDGFR-α+ cells after 5 days differen-
tiation (Fig. S1b). However, differentiated ESCs began to die
after 7 days in culture and the number of PDGFR-α+ cells was
greatly reduced (data not shown). Time-course gene
expression profiling by RT-PCR revealed that the genes
Figure 1 Paraxial mesodermal differentiation induced by bone morphogenetic protein 4 (BMP4) in serum free culture. (a) Dose-
dependent induction of platelet-derived growth factor receptor-α (PDGFR-α) expression by BMP4 in ESC differentiation culture. The
percentage indicates the proportion of PDGFR-α+ cells. Two hundred thousand ESCs were differentiated in SF-O3 with the indicated
BMP4 concentration for 6 days. More than 1 ng/ml BMP4 effectively induced PDGFR-α+ cells. (b and c) Cell density affects the
differentiation of the PDGFR-α+ cells. ESC differentiated in SF-O3 with 1 ng/ml BMP4 at the indicated starting cell density for 6 days.
High starting cell density inhibited the expression of PDGFR-α in differentiated ESCs. The cell numbers of the experiments in (b) are
shown in (c). White bars indicate the number of plated cells and gray bars indicate the number of harvested cells after 6 days
differentiation. The PDGFR-α+ cells (black bars) were induced most efficiently at the starting cell density 2×105/10-cm dish. The
differentiated PDGFR-α+ cells increased 5-fold over input cell density (triangle dots). Error bars indicate SEM (n=3). (d) Time-course
analyses of BMP4 induction culture. Upper row: The PDGFR-α+ cells emerged after 4 days of differentiation and reached peak levels a
day later. Lower row: Morphological changes of differentiated ESCs in BMP4 induction culture. The bar indicates 200 μm. The cell
numbers of the experiments in (d) are shown in (e). PDGFR-α+ cells increased in a time-dependent manner. (f) Gene expression
profiles of ESC differentiation determined by RT-PCR. Undifferentiated ESCs (d0) express only Oct3/4. Sequential expression of genes
involved in paraxial mesoderm development is observed in the cells induced with BMP4. The expression levels of mesodermal genes in
BMP4 induction are higher than in serum-containing differentiation culture.
159Serum-free induction of ESC to paraxial mesodermwhich play an important role in mesodermal development
were expressed in this BMP4-mediated induction system (Fig.
1f). The expression of T (Wilkinson et al., 1990), which wasthe earliest pan-mesodermal marker, was detected on Day 3
and peaked around Day 4 or 5. Specific markers for paraxial
mesoderm and somitogenesis, such as Msgn1 (Yoon et al.,
160 H. Sakurai et al.2000) and Tbx6 (Chapman and Papaioannou, 1998), emerged
after 4 days of differentiation and decreased by Day 6. The
expressions of Pax3 (Williams and Ordahl, 1994) and Cdh11
(Kimura et al., 1995), which play important roles in
dermomyotome and sclerotome formation from the somite,
respectively, were detected on Day 5 and peaked between
Day 5 and Day 6. On the other hand, the undifferentiated
marker gene, Oct3/4, was expressed strongly at Day 3 and
diminished as differentiation progressed (Fig. 1f). These
sequential expression patterns of mesodermal genes and the
downregulation of an undifferentiated marker gene suggest
that the BMP4 induction system is similar to embryonic
mesodermal development.Gene expression profiles of the mesodermal subsets
in differentiated ESCs
Next, we sorted two subpopulations defined by expression of
PDGFR-α and ECD (shown in Fig. 2a) after 5 days and 7 days ofFigure 2 Gene expression profiles of the mesodermal subsets i
BMP4 induction culture. Differentiated cells are sorted as indicated
PDGFR-α+∼low/ECDlow population (fractions 2 and 4) mainly expresses
Pax9, Pax3, and Pax7, while the PDGFR-α-/ECD+ population (fractio
cells that express Oct-3/4, Nanog, and Foxa2. However, lateral meso
distinguishable by this gating. The PDGFR-α+∼low/ECDlow cells are nainduced differentiation. Each population was analyzed for its
gene expression pattern to determine its character (Fig. 2b).
As expected the PDGFR-α+∼low/ECDlow population expressed
paraxial mesodermal and somitegenesis-related markers
such as Tbx6, Dll1 (Bettenhausen et al., 1995), and Msgn1
(Fig. 2b). The PDGFR-α+∼low/ECDlow population also domi-
nantly expressed genes involved in the formation of
sclerotome and dermomyotome. The sclerotome markers
Cdh11 and Pax9 (Peters et al., 1998) and the dermomyotome
markers Pax3 and Pax7 (Jostes et al., 1990) were mainly
detected in this population (Fig. 2b). On the other hand,
undifferentiated markers such as Oct3/4 and Nanog,
endoderm marker Foxa2, and ectoderm marker Sox1 were
negative in this PDGFR-α+/ECDlow population (Fig. 2b). Early
treatment of BMP4 inhibited neural cell differentiation in
serum-free ESC culture (Mizuseki et al., 2003). A neural cell
marker Sox1 was not detected in all fractions; thus
neurogenic differentiation did not occur in this BMP4-
mediated ESC induction system (Fig. 2b). Taken together,
we successfully isolated the paraxial mesodermal progenitorn differentiated ESCs. (a) Characterization of the fractions in
and gene expression patterns are analyzed by RT-PCR. (b) The
paraxial mesodermal markers such as Tbx6, Dll1, Msgn1, Cdh11,
n 3 and 5) represents undifferentiated and endodermal lineage
dermal lineage cells that express Runx1 and VE-cadherin are not
med paraxial mesodermal progenitor cells (PMPs).
161Serum-free induction of ESC to paraxial mesodermcells (PMPs) from ESC culture as the PDGFR-α+∼low/ECDlow
population and constituted up to 60% PMPs after 5 days of
differentiation (Fig. 2a). Remarkably, the proportion of PMPs
reached ∼85% after 7 days of ESC differentiation in BMP4
(Fig. 2a).
Oct3/4, Nanog, and Foxa2 were mainly expressed in the
PDGFR-α-/ECD+ population (Fig. 2b). Because ECD monitors
both undifferentiated cells and endodermal cells during ESC
differentiation (Nishikawa et al., 1998), the PDGFR-α-/ECD+
population represented residual undifferentiated cells and
differentiated endodermal cells. Furthermore, early pan-
mesodermal marker T was detected mainly in the PDGFR-α-/
ECD+ population. This result suggests that the PDGFR-α-/
ECD+ population contains undifferentiated cells and early
mesodermal progenitors resembling the cells in the primitive
streak of embryos just before migration. Focusing on lateral
mesodermal cells, the lateral mesodermal marker VEGFR2
(Shalaby et al., 1997) was strongly expressed in the PDGFR-
α+∼low/ECDlow population but mildly in the PDGFR-α-/ECD+
population (Fig. 2b). The hematopoietic cell marker Runx1
(Okada et al., 1998) and the endothelial cell marker VE-
cadherin (Breier et al., 1996) were detected at Day 7 of
differentiation in both populations. These results show that
the lateral mesodermal progenitor cells cannot be identified
by the expression of PDGFR-α and ECD during ESC differen-
tiation. We conclude that addition of BMP4 to SF-O3 medium
permits efficient induction of paraxial mesodermal progen-
itor cells (PDGFR-α+∼low/ECDlow) from mouse ESCs.Osteogenic and chondrogenic potentials of
BMP4-induced paraxial mesodermal progenitor
cells in vitro and in vivo
Next, we investigated the in vitro and in vivo osteogenic and
chondrogenic potentials of PMPs induced by BMP4. PMPs
differentiated into osteocytes containing an abundant
calcium matrix as revealed by Alizarin Red-positive staining
(Fig. 3a, left column). On the other hand, the PDGFR-α-/
ECD+ population exhibited limited potential to form calcium-
positive osteocytes as indicated by reduced Alizarin Red
staining (Fig. 3a, right column). This staining pattern
suggests that only a part of the PDGFR-α-/ECD+ population,
which represents an undifferentiated lineage, could respond
to osteogenic stimulation. In in vitro chondrogenesis, PMPs
could form an Alcian blue-positive chondrocyte colony in the
center of a micromass high-density cell culture (Fig. 3b,
left). On the other hand, the PDGFR-α-/ECD+ population did
not form any Alcian blue-positive chondrocytes under the
same conditions (Fig. 3b, right) (n=4). These results
indicated that PMPs induced by BMP4 had enough potential
to differentiate into both osteocytes and chondrocytes in
vitro.
To test the potential of PMPs to give rise to osteocytes in
vivo, we transplanted the PMPs and PDGFR-α-/ECD+ popula-
tion derived from CCE/nLacZ ESCs into the tibial bone
marrow of immunodeficient mice. Four weeks after trans-
plantation of PMPs, some LacZ-positive cells were detected
in the tibial bone, especially in the trabecular bone (Fig. 3c,
upper row) (n=3). However, no LacZ-positive cells were
observed following transplantation of the PDGFR-α-/ECD+
population (data not shown) (n=3). Although a part of ESC-derived LacZ-positive cells were located in bone matrix, the
majority of them were observed at the edge of trabecular
bone (Fig. 3c, arrowhead). Because this localization pattern
was similar to that of osteoblasts, and PMPs express Cdh11
(an osteoblast marker) (Fig. 2b), we assessed alkaline
phosphatase (AP) activity to confirm the presence of
osteoblasts (Fig. 3c, lower row). We detected many AP+
cells at the edge of the trabecular bone, and some of the AP+
cells were LacZ positive in the nucleus (Fig. 3c, arrow).
Therefore, at least some of the PMPs had the potential to
differentiate into osteocytes, and osteoblast in vivo.
Furthermore, PMPs also had the potential to differentiate
to bone-like and cartilage-like tissues even when they were
in microenvironments that did not normally support osteo-
genesis or chondrogenesis (Fig. 3d). CCE/nLacZ ESC-derived
PMPs and PDGFR-α-/ECD+ cells were directly injected into
injured quadriceps femoris muscle. The engrafted tissues
were then analyzed 4 weeks after transplantation. Surpris-
ingly, ectopic cartilage and bone were observed in engrafted
skeletal muscle (Fig. 3d, upper row) (n=3). We could detect
cartilage formation in all three independent experiments,
and in one experiment, bone formation was observed
adjacent to the ectopic cartilage (Fig. 3d, upper left). The
ectopic inductions of cartilage and bone were covered with a
capsule and were not part of a teratoma because they did not
contain any other tissues. They were derived from engrafted
PMPs expressing LacZ (Fig. 3d, lower panels). In contrast, the
PDGFR-α-/ECD+ population formed a teratoma which includ-
ed differentiated striated muscle or cartilage in injured
muscle (n=3, Fig. S1c). These results demonstrated that
PMPs exhibited sufficient potential to differentiate to
osteocytes and chondrocytes in vivo without forming
teratomas.
PMPs did not differentiate into myogenic lineage cells
even when they were in an environment which supported
myogenesis (n=8, not shown). BMPs are inhibitory factors for
myogenic regulatory genes such as Myf5 (Ott et al., 1991) or
MyoD (Sassoon et al., 1989) during mouse skeletal muscle
development (Reshef et al., 1998). Wnt signaling promotes
myogenic regulatory genes during mouse development
(Parker et al., 2003). Therefore, we attempted to generate
myogenic progenitors from ESCs by excluding BMP signals and
instead inducing Wnt signals with lithium chloride (LiCl),
which translocates cytoplasmic β-catenin to the nucleus by
inhibiting GSK-3 (Yamamoto et al., 1999).Myogenic induction with removal of BMP4 and
addition of LiCl in serum-free ESC culture
We analyzed the expression of myogenic regulatory genes on
Day 7 of differentiation after 3 or 7 days of BMP4 treatment
(Fig. 4a). Although a dermomyotome marker Pax3 was
expressed under both culture conditions, faint expression
of Myf5 and MyoD was detected only when BMP4 was
removed after 3 days. BMP4 is known to inhibit MyoD but
not affect Pax3 expression (Pourquie et al., 1996). We also
found that adding LiCl after removal of BMP4 enhanced the
expression of Myf5 and MyoD (Fig. 4a). The expression levels
of Myf5 and MyoD were higher in the presence of 2.5 to 10 mM
LiCl. Thus, LiCl was used at 5 mM in the following
experiments. LiCl treatment for 7 days did not induce
162 H. Sakurai et al.expression of either of the myogenic regulatory genes or the
dermomyotome marker Pax3. Furthermore, it was reported
that BMP4 is necessary for induction of primitive streak
mesoderm in hematopoiesis from ESCs (Pick et al., 2007;
Park et al., 2004). These results suggested that early
treatment of ESCs with BMP4 was essential for primitivestreak-like mesodermal differentiation of ESCs in culture.
The addition of LiCl caused an intranucleic change of β-
catenin localization (Fig. 4b). In the case of BMP4 treatment
alone, β-catenin localized to the cytoplasm of differentiated
ESCs (Fig. 4b, upper row). Adding 5 mM LiCl after BMP4
removal on Day 3 of ESC differentiation, β-catenin was
163Serum-free induction of ESC to paraxial mesodermconcentrated in the nuclei of differentiated ESCs (Fig. 4b,
lower row). Thus, the addition of LiCl stimulated the
canonical Wnt signaling pathway.
We determined the optimal periods of BMP4 and LiCl
treatments (Fig. 4c, upper row). A high level of MyoD
expression was observed when BMP4 was removed on Day 3–
4 followed by 3–4 days of LiCl treatment. Extending BMP4 or
LiCl induction reduced the expression of Myf5 and MyoD and
enhanced the expression of MyoD, respectively.
In the following studies, we exposed cells to BMP4 at 1 ng/
ml for the first 3 days and then replaced it with 5 mM LiCl for
4 days. We termed this technique “myogenic progenitor
induction” (MPI). We analyzed the time course of PDGFR-α
expression during MPI (Fig. 4c, lower row). The expression of
PDGFR-α increased in a time-dependent fashion, and after 4
days of LiCl treatment, 74% of the differentiated ESCs were
PDGFR-α+. The total PDGFR-α+ cell number was dramatically
increased (more than 50-fold compared to the number of
input ESCs) with MPI (Fig. 4d).
We profiled gene expression in three cell populations (Fig.
4e) after MPI. The PDGFR-α+/ECDlow and PDGFR-αlow/ECDlow
populations strongly expressed dermomyotome markers,
Pax3 and Pax7 (Jostes et al., 1990), akin to BMP4 treatment,
and also the myogenic regulatory genes, Myf5 and MyoD (Fig.
4e). Thus, myogenic progenitors were included in the
paraxial mesodermal progenitor cells subjected to MPI. The
PDGFR-α-/ECD+ population also expressed Pax7 weakly;
however, this population expressed the neural marker Sox1
(Fig. 4e). Pax7 expression in the PDGFR-α-/ECD+ population
is indicative of neural differentiation since Pax7 is detected
in the nervous system and in myogenic precursors during
mouse development (Jostes et al., 1990). The lateral
mesodermal markers VEGFR2, Runx1, and VE-cadherin
were expressed in the PMPs and in the PDGFR-α-ECD+
population (Fig. 4e). An intermediate mesodermal marker
Pax2 (Torres et al., 1995) was detected in the PMPs and the
intermediate mesodermal marker Lhx1 (Fujii et al., 1994)
was observed in all three subpopulations (Fig. 4e). These
results suggest that all three types of primitive streak-
derived mesoderm cells can be induced by MPI. However,
sorting by PDGFR-α and ECD expression can only identify the
paraxial mesodermal progenitor cells. Oct3/4, Nanog, and
Foxa2 were strongly expressed in the PDGFR-α-/ECD+
population similar to BMP4-mediated induction. The
PDGFR-αlow/ECDlow population subjected to MPI expressedFigure 3 Osteogenic and chondrogenic potentials of BMP4-induced
vitro osteogenesis of differentiated CCE ESCs 28 days after induc
mesodermal progenitor cells (PMPs) differentiated into osteocytes pr
PDGFR-α-/ECD+ population showed limited osteogenic potential ind
chondrogenesis of differentiated CCE ESCs 21 days after chondrocyt
chondrocytes (n=4, each). The bars indicate 100 μm. (c) PMPs cultu
vivo. The CCE/nLacZ ESC-derived PDGFR-α+∼low/ECDlow population w
(n=3). Twenty-eight days later, β-galactosidase staining was perform
have light blue nuclear staining are observed in the trabecular bon
positive for alkaline phosphatase (AP) indicative of osteoblasts. The
indicate 10 μm. (d) Differentiation potential of the PMPs toward c
α+∼low/ECDlow population was directly transplanted into injured quad
eight days later, β-galactosidase staining was performed to detect
detected in engrafted muscle tissues. The bars indicate 100 μm, and
ectopic cartilage was derived from engrafted cells as confirmed byFoxa2 and Oct3/4 only slightly (Fig. 4e). We conclude that
the MPI system permits a fair induction of myogenic
progenitor cells in the PDGFR-α+∼low/ECDlow population.Skeletal muscle cell differentiation of PMPs in
chemically defined medium after in vitro MPI
Next, we asked whether the MPI procedure could induce
PMPs to form mature myofibers in vitro. In mouse skeletal
muscle regeneration, growth factors such as insulin-like
growth factor-1 (IGF-1), hepatocyte growth factor (HGF), or
basic fibroblast growth factor (bFGF) activate proliferation
of Myf5+/MyoD+ myoblasts (Charge and Rudnicki, 2004). IGF-
1 also induces terminal differentiation with Myogenin
(Sassoon et al., 1989) expression (Charge and Rudnicki,
2004). Subsequently, IGF-1 and HGF promoted fusion of
myoblasts and generation of new myofibers. We optimized
the culture system for skeletal muscle formation in vitro
using the protocol summarized in Fig. 5a. Collagen type I was
selected as a suitable matrix for inducing myogenic cells
after sorting based on the expression level of Myogenin (Fig.
S1d). The optimal periods for HGF and bFGF induction were
determined by cellular expression levels of MyoD and
Myogenin (Fig. 5b). Although IGF-1 alone could promote
faint Myogenin expression in this culture, adding both HGF
and bFGF for 3 days increased MyoD and Myogenin expression
(Fig. 5b). These results indicate that HGF and bFGF are
necessary for maintenance of the MyoD+ myoblast prolifer-
ation. Longer treatment of cultures with HGF and bFGF
completely inhibited Myogenin expression (Fig. 5b). This
could be explained by the ability of FGF to inactivate
myogenic transcription factors (Li et al., 1992). Myogenin
expression was confirmed by immunohistochemistry (Fig.
5c). Some spindle-shaped cells with mono- or multinuclear
Myogenin staining were observed in the PMP-derived
differentiation culture (Fig 5c). Myogenin+ cells were not
detected in the PDGFR-α-/ECD+ cell-derived culture. To-
gether with the myogenic regulatory gene expression
patterns presented in Fig. 4e, this result suggests that all
of the myogenic progenitor cells are derived from the PMPs.
However, many Giemsa-positive, Myogenin-negative cells
were found in the PMP-derived culture. Approximately 11%
of the cells were Myogenin+ in the PMP-derived culture,
while no cells expressed Myogenin in the PDGFR-α-/ECD+-paraxial mesodermal progenitor cells in vitro and in vivo. (a) In
tion in osteocytic culture. The PDGFR-α+∼low/ECDlow paraxial
oducing an Alizarin red-positive calcium matrix (n=4, each). The
icating faint calcium deposits around the colonies. (b) In vitro
ic induction culture. The PMPs gave rise to Alcian blue-positive
red with BMP4 differentiated toward the osteogenic lineage in
as grafted into the tibial bone marrow of immunodeficient mice
ed to detect engrafted cells. Upper row: LacZ-positive cells that
e (arrowheads). Lower row: Some LacZ-positive cells are also
bars in left panels indicate 100 μm, and the bars in right panels
artilage and bone in vivo. The CCE/nLacZ ESC-derived PDGFR-
ricep femoris muscles of immunodeficient mice (n=3). Twenty-
engrafted cells. Upper row: Ectopic cartilage and bone were
the bars in right lower panels indicate 10 μm. Lower row: The
the expression of β-galactosidase. The bars indicate 100 μm.
164 H. Sakurai et al.derived culture (Fig. 5d). Indeed, all the myogenic progen-
itor cells were included in PMPs, but the PMPs in the MPI
culture were not a pure population of myogenic progenitors,and contained many other cell lineages. Further treatment
with IGF-1 and HGF promoted differentiation into mature
skeletal muscle cells which expressed skeletal muscle Actin
Figure 4 Myogenic progenitor cells are induced from ESCs by transient exposure to BMP4 and subsequent LiCl treatment in chemically
definedmedia. (a) The expressions of myogenic regulatory genes are assessed by RT-PCR during the 7 days of ESC culture. (b) The addition
of LiCl activated the canonical Wnt signaling pathway. BMP4 induced cells express β-catenin on the cytoplasm and cell surface. Four days
of LiCl treatment after 3 days of BMP4 treatment showed concentrated β-catenin expression in the nuclei. (c) Upper row: Strong
expression ofMyoD after 3 days of treatmentwith BMP followedby 4 days of 5mMLiCl treatment, or 4 days of treatmentwithBMP followed
by 3 days of exposure to 5 mM LiCl. Lower row: PDGFR-α expression increases in a time-dependent fashion during treatment with LiCl.
Percentages indicate the proportion of PDGFR-α+ cells in differentiated ESCs. The cell numbers of the experiments in (c) are shown in (d).
PDGFR-α+ cells increased in a time-dependentmanner. The differentiated PDGFR-α+ cells increasedmore than 50-fold compared to input
cells. Myogenic progenitor induction (MPI) refers to 1 ng/ml BMP4 treatment for 3 days followed by 4 days of exposure to 5 mM LiCl with
1×105 input ESCs per 10-cm dish. (e) Characterization of the fractions in MPI culture. Differentiated cells were sorted as indicated in the
upper panel and gene expression patterns were analyzed by RT-PCR. The PDGFR-α+∼low/ECDlow population contains the myogenic
progenitor lineage, while the PDGFR-α-/ECD+ cells include undifferentiated cells, endodermal cells, and ectodermal cells. Other meso-
dermal lineage markers, such as lateral mesoderm marker and intermediate mesoderm marker, were detected in all three populations.
Figure 5 Skeletal muscle differentiation of PDGFR-α+ cells in myogenic progenitor induction culture. (a) Protocol for inducing
mature skeletal muscle cells. (b) HGF and bFGF treatment enhances the expression of MyoD and Myogenin by sorted PMPs in culture.
Three or 4 days of treatment with HGF and bFGF increased MyoD andmyogenin expression. Shorter HGF and bFGF treatment diminished
MyoD and Myogenin expression, and 7 days of HGF and bFGF treatment repressed Myogenin expression. (c) Immunohistochemical
confirmation of skeletal muscle cells (n=3, each). Upper panels: The PMPs could differentiate into Myogenin+ cells with brown nuclear
staining. Multi Myogenin+ nuclei were observed in one fiber (arrowhead). PDGFR-α-/ECD+ cells did not differentiate into Myogenin+ cells
under these conditions. Lower panels: Nuclear counterstaining by Giemsa solution. The PMPs also differentiated into Myogenin- cells.
(d) Giemsa+ (white bars) and Myogenin+ cells (gray bars) in each well were counted. Myogenin+ cells (black dots) were approximately
11% in the PMPs. Error bars indicate SEM (n=3). (e) PMPs could differentiate into skeletal muscle Actin+ cells with brown staining.
PDGFR-α-/ECD+ cells did not differentiate into skeletal muscle Actin+ cells under these conditions. The bars indicate 50 μm.
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166 H. Sakurai et al.(Fig. 5e). We conclude that using chemically defined media
successfully initiates differentiation of skeletal muscle from
ESCs akin to mouse skeletal muscle development.Discussion
During embryogenesis, development is controlled by the
sequential actions of many signaling pathways. To under-
stand the molecular mechanisms driving differentiation, it is
necessary to examine the activities of these molecules on
isolated populations that represent distinct stages of
development. The ESC differentiation system is a suitable
model for this approach, as it provides access to such
populations and it responds well to the activation and
suppression of growth factors by chemically defined condi-
tions (Nishikawa et al., 2007). Our results have demonstrated
the bidirectional differentiation pathways that induce
paraxial mesodermal lineages from ESCs (Fig. 6).
BMP4 induces early mesodermal precursors that represent
primitive streak-type mesoderm (Johansson and Wiles, 1995;
Ng et al., 2005). Recently, Nostro et al. showed that BMP4
acts indirectly on the formation of primitive streak-type
mesoderm (Nostro et al., 2008). They demonstrated that
Wnt and Activin/Nodal are essential for the establishment of
the primitive streak in culture, and BMP4 induces the Nodal
and Wnt pathways (Nostro et al., 2008). Subsequently, BMP4
exerts a posteriorizing effect on the cultured primitive
streak-type cells, and BMP4 induces cells that give rise to the
posterior mesoderm lineages (Nostro et al., 2008). In another
recent study, Willems and Leyns demonstrated that the
addition of BMP4 in serum-free media promoted posterior
mesoderm differentiation, while Activin A induced anterior
mesoendoderm differentiation (Willems and Leyns, 2008).
Our findings support the idea that early BMP4 treatment
promotes the differentiation of early mesodermal progeni-Figure 6 Schematic model of the bidirectional differentiation
differentiate selectively into the early primitive streak-type mesod
BMP4 treatment forces the cells to differentiate into osteochondro
ECDlow cells. These osteochondrogenic progenitor cells can differe
Alternatively, removal of BMP4 on Day 3 of differentiation and 4 da
myogenic progenitor cells which are defined as the PDGFR-α+∼low/EC
mature skeletal muscle cells in the presence of IGF-1, HGF, and bFGtors from ESCs by acting as an activator of endogenous
Activin/Nodal and Wnt signals (Fig. 6). BMP4 then can direct
the early mesodermal precursor cells to differentiate further
into the posterior primitive streak-type mesoderm (Fig. 6).
As presented in Fig. 4a, Pax3, the marker of somites and
dermomyotomes, was significantly expressed even in 4 days
of factor-free culture after 3 days of BMP4 treatment. Thus,
3 days of BMP4 treatment in differentiating ESCs promotes
the expression of somitic genes following T and paraxial
mesodermal gene expression. Here, we demonstrate that
BMP4 treatment for 3 days induces ESCs to differentiate into
posterior primitive streak mesodermal lineages (Fig. 6). Cell
density, in addition to extrinsic factors, also affects 2-D
mesodermal differentiation. Lower cell density promotes the
emergence of paraxial mesodermal progenitors, but higher
cell density does not. In the higher cell density studies, live
cell number is dramatically reduced, indicating that the
proliferation of ESCs is inhibited during the 2-D differenti-
ation system.
Prolonged BMP4 treatment induces the emergence of the
osteochondrogenic progenitors identified as the PDGFR-
α+∼low/ECDlow paraxial mesodermal progenitor cells (Fig. 6).
The BMP4-induced PMPs exhibited significant potential to
differentiate to osteocytes and chondrocytes in vitro and in
vivo. Furthermore, the BMP4-induced PMPs seemed to
differentiate into osteoblasts. Further experiments will be
necessary to determine if osteoblasts derived from the PMPs
are functional. PMP-derived osteoblasts could be used for
regenerative therapy of diseased bone. We also showed that
teratomas were not formed after transplantation of the
PDGFR-α-/ECD+ population into bone marrow. We have
discovered that transplantation of low numbers of the ESCs
(b 1×105) beneath the renal capsule forms a teratoma, but
the same number of cells transplanted into muscle does not
(unpublished data). This may be explained by different tissue
microenvironments. The microenvironment of bone marrowprocess from ESCs to paraxial mesodermal derivatives. ESCs
ermal precursors in BMP4 containing serum-free media. Further
genic progenitor cells which are defined as the PDGFR-α+∼low/
ntiate into osteocytes and chondrocytes in vitro and in vivo.
ys of exposure to LiCl under serum-free conditions induces the
Dlow cells. These myogenic progenitor cells can differentiate into
F in serum-free media.
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when engrafted at the cell number of 5×105.
Early removal of BMP4 followed by LiCl treatment
promotes the differentiation of PMPs to myogenic progeni-
tors (Fig. 6). In mouse embryogenesis, the establishment of
the myotome from the dermomyotome is stimulated by Wnt
signaling and by the expression of Noggin which inhibits the
BMP signaling pathway (Parker et al., 2003). Our culture
system mimics these developmental events by removing
BMP4 after the induction of paraxial mesodermal progenitors
and adding LiCl which inhibits GSK-3 and causes translocation
of cytoplasmic β-catenin to the nucleus (Yamamoto et al.,
1999). The myogenic progenitor cells induced by the above
method express Myf5 and MyoD, and can differentiate into
mature skeletal muscle cells in vitro akin to in vivo myotube
formation (Charge and Rudnicki, 2004). However, under
these culture conditions not all of the cells in the PMPs have
myogenic potential, as we detect many cells that do not
differentiate into skeletal muscle (Fig. 5c). The PMPs express
lateral mesodermal markers or intermediate mesodermal
markers, and only 11% of the PMPs were able to differentiate
into Myogenin+ myogenic cells. However, we also demon-
strate that all of the myogenic progenitors are included
within the PMPs. We can successfully separate the myogenic
progenitors from residual undifferentiated ESCs by monitor-
ing the expression of PDGFR-α and ECD, but such heteroge-
neity in the PDGFR-α+∼low/ECDlow population should be
overcome by further marker selection to distinguish the
myogenic progenitors specifically.
Finally, we can selectively induce two distinct types of
paraxial mesodermal progenitors, osteochondrogenic or
myogenic progenitors, from BMP4-treated posterior primitive
streak-like mesodermal precursors by further treatment with
BMP4 or LiCl (Fig. 6). Stepwise specification under chemically
defined conditions will be a key method for inducing mature
lineage cells from uncommitted early precursor cells.Materials and methods
In vitro cell culture and ESC differentiate
CCE ESCs and the ESCs expressing the LacZ gene (CCE/nLacZ)
were kindly provided by Dr. S. Nishikawa. CCE/nLacZ ESCs
were maintained as described previously (Nishikawa et al.,
1998). For paraxial mesoderm differentiation, 2×105 ESCs
were plated on a 10-cm dish coated with type IV collagen
(Nitta Gelatin, Inc., Osaka, Japan) and differentiated in a
serum-free culture medium, SF-O3 (Sanko Junyaku, Tokyo,
Japan) supplemented with 0.2% bovine serum albumin (BSA),
0.1 mM 2-mercaptoethanol, and 1 ng/ml recombinant human
BMP4 (R&D Systems Inc., Minneapolis, MN). Four to 6 days
later, osteogenic and chondrogenic mesodermal progenitor
cells were obtained as PDGFR-α+∼low/ECDlow cells. For
further osteocytic and chondrocytic induction, the PDGFR-
α+∼low/ECDlow cells at Day 5, which were sorted as described
below, were recultured as described previously (Sakurai et
al., 2006). For osteocytic induction, 1×105 cells were plated
in a gelatin-coated 24-well dish. For chondrocytic induction,
8×105 cells were spotted on a 24-well culture plate.
For myogenic induction mesodermal progenitor cells were
differentiated for 3 days with BMP4 and then themedium waschanged to SF-O3 supplemented with 5 mM LiCl for 4 days.
For further induction, the cells were sorted as described
below and were recultured on collagen type I-coated 24-well
trays (AGC Techno Glass, Funabashi, Japan) in SF-O3 with
2 ng/ml insulin-like growth factor-1 (R&D Systems), 10 ng/ml
hepatocyte growth factor (R&D systems), and 2 ng/ml basic
fibroblast growth factor (R&D Systems). Three days after
reculture, the medium was changed again to SF-O3 with
2 ng/ml IGF-1. Four days later, the medium was changed
again to SF-O3 with 2 ng/ml IGF-1 and 10 ng/ml HGF and the
cells were cultured for 7 days (Fig. 5a).
Antibodies, cell staining, FACS analyses, and cell
sorting
Rat monoclonal antibodies (MoAbs), APA5 (anti-PDGFR-α)
(Kataoka et al., 1997) and ECCD2 (anti-ECD) (Sakurai et al.,
2006), were kindly provided by Dr. S. Nishikawa. R-
Phycoerythrin (R-PE)-conjugated streptavidin (BD Pharmin-
gen, San Diego, CA) was used to detect biotinylated-APA5
antibody. ECCD2 MoAbs were directly conjugated by a
standard method using allophycocyanin (APC). We used the
rat MoAbs, anti-CD8-PE conjugated conjugated (BD Pharmin-
gen) and anti-CD4-APC (BD Pharmingen), as the isotype
controls for MoAbs above (Fig. S1a).
Cultured cells were harvested and collected in 0.05%
trypsin-EDTA (GIBCO, Grand Island, NY). Single-cell suspen-
sions were stained as previously described (Nishikawa et al.,
1998) and analyzed with a FACSCalibur or sorted a
FACSVantage-HG and a FACSAria (Becton Dickinson and
Company, Franklin Lakes, NJ).
Transplantation of ESC-derived mesodermal
progenitors into immunodeficient mice
We carried out mouse experiments according to protocols
approved by the Animal Care and Use Committee of Nagoya
University Graduate School of Medicine. The PDGFR-α+∼low/
ECDlow fraction (Fig. 2a, population 2) and the PDGFR-α-/
ECD+ fraction (Fig. 2a, population 3) were purified and
collected by FACS (N 5×105 cells). Cells were resuspended at
a density of 2.5×104 cells/μl in α-minimal essential medium
(αMEM) (Gibco) supplemented with 10% fetal bovine serum
(FBS) (Roche Diagnostics, Basel, Switzerland) and 100 μM 2-
mercaptoethanol (2-ME). For intramuscular transplantation,
a quadriceps femoris muscle of a KSN nude mouse (Japan
SLC, Inc., Hamamatsu, Japan) was injured by direct
cramping following diethyl ether anesthesia. Twenty micro-
liters of cell suspension (5×105 cells) was directly injected
into the injured quadriceps of each mouse. For intrabone
marrow transplantation, animals were sedated with diethyl
ether anesthesia and 20 μl of cell suspension (5×105 cells)
was directly injected into the tibial bone accessed through
the knee joint using a 21-G needle.
RT-PCR analysis
Total RNA was isolated using TRIzol reagent (Invitrogen,
Carlsbad, CA) according to the manufacturer's recom-
mended protocol. Residual genomic DNA was digested and
removed using DNase I (Roche) treatment. First-strand cDNA
168 H. Sakurai et al.was synthesized using the Superscript First-Strand Synthesis
System (Invitrogen) and an oligo d(T)12-18 primer. The
cDNA was diluted with DNase free water at a concentration
of 10 ng/μl. RT-PCR was performed using the Ex-Taq PCR kit
(Takara, Otsu, Japan) according to the manufacturer's
instructions. The primers are listed in Supplementary
Table 1.
Whole mount β-galactosidase staining
For whole mount detection of β-galactosidase activity,
transplanted tissue was extracted and fixed with 2%
formaldehyde, 0.2% glutaraldehyde, and 0.02% Nonidet-P-
40 in PBS for 2 h on ice. The fixed sample was washed twice in
PBS for 1 h at 4 °C. β-Galactosidase activity was detected by
incubating the sample in 3.1 mM potassium ferricyanide,
3.1 mM potassium ferrocyanide, and 1 mM MgCl2 in PBS with
0.4 mg/ml X-gal (Gibco) overnight at 37 °C. The stained
sample was washed twice in PBS at 4 °C for 30 min, frozen in
Tissue-Tek OCT Compound (Sakura Finetek, Torrance, CA),
and cut into 5-μm sections with a cryostat. The sectioned
sample was counterstained with hematoxylin-eosin or by
alkaline phosphatase (AP) staining. AP staining was per-
formed by using an alkaline phosphatase kit (Sigma-Aldrich,
St. Louis, MO) according to the manufacturer's protocol.
Histochemistry for osteogenesis and chondrogenesis
Alizarin Red staining and Alcian blue staining were per-
formed as previously described (Muraglia et al., 2003).
Briefly, cultured cells were fixed with 4% paraformaldehyde
in PBS for 5 min at room temperature (RT). The fixed cells
were washed twice in PBS for 5 min at RT. For calcium
detection, the fixed cells were incubated in 1% Alizarin Red S
(Sigma) solution for 5 min at RT, and then cells were washed
five times in PBS at RT. For the detection of mucopolysac-
charide of cartilage, the fixed cells were incubated in 3%
acetate solution for 5 min at RT and then incubated in 1%
Alucian blue 8GX (Sigma) and 3% acetate solution for 30 min
at RT. The cells were washed five times in 3% acetate
solution and twice in PBS.
Immunohistochemistry
Immunohistochemical analyses were performed as previously
described (Sakurai et al., 2008). Antibodies were used as
follows: rabbit anti-β-galactosidase (Chemicon, Temecula,
CA) at 1:2000, rabbit anti-β-catenin (Sigma) at 1:500, rabbit
anti-myogenin (Santa Cruz Biotechnology, Inc., Santa Cruz,
CA) at 1:200, and rabbit anti-skeletal muscle Actin (Abcam,
Cambridge, MA) at 1:100. R-PE-conjugated anti-rabbit IgG
(Southern Biotech) was used as the secondary antibody for
rabbit anti- β-galactosidase and rabbit anti-β-catenin at
1:1000. HRP-conjugated anti-rabbit IgG (Chemicon) was used
as the secondary antibody for anti-myogenin and anti-
skeletal muscle Actin. Purified rabbit polyclonal IgG (Sigma)
was used as control IgG for rabbit anti- β-galactosidase. In
culture cell immunohistochemistry, Giemsa's solution (Merck)
was used for nuclear counterstaining. In fluorescent immuno-
histochemistry, 4′,6-diamidino-2-phenyindole (DAPI, Sigma)
was used for nuclear counterstaining.Acknowledgments
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